Filing Details
- Accession Number:
- 0001127602-22-027583
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-15 17:39:53
- Reporting Period:
- 2022-12-13
- Accepted Time:
- 2022-12-15 17:39:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 97745 | Thermo Fisher Scientific Inc. | TMO | Measuring & Controlling Devices, Nec (3829) | 042209186 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1844600 | Gianluca Pettiti | 168 Third Avenue Waltham MA 02451 | Executive Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-12-13 | 775 | $210.68 | 17,225 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2022-12-13 | 4,200 | $210.68 | 21,425 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-12-13 | 4,975 | $576.84 | 16,450 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-12-14 | 2,000 | $569.11 | 14,450 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2022-12-13 | 775 | $0.00 | 775 | $210.68 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2022-12-13 | 4,200 | $0.00 | 4,200 | $210.68 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2025-02-27 | No | 4 | M | Direct | |
| 0 | 2025-02-27 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 1, 2022.
- The option vested in four equal installments on February 27, 2019, 2020, 2021, and 2022.
Billionaire Hedge Funds
